The global Radiotherapy Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (External beam, Internal beam), By End-User (Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers).
Radiotherapy, also known as radiation therapy, is a key modality in cancer treatment that uses high-energy radiation beams to destroy cancer cells and shrink tumors. The Radiotherapy Devices Market comprises linear accelerators, brachytherapy systems, radiation planning software, treatment accessories, and quality assurance tools used by radiation oncologists and healthcare providers in cancer care settings. Technological innovations such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), image-guided radiation therapy (IGRT), and proton therapy have enhanced treatment precision, dose delivery accuracy, and patient safety in radiotherapy. Market trends include increasing cancer incidence rates, demand for advanced radiotherapy equipment, research on personalized treatment protocols, and collaborations for clinical outcomes research in radiotherapy efficacy and safety.
The global Radiotherapy Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Radiotherapy Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Radiotherapy Devices Industry include- AngioDynamics Inc, Becton, Dickinson and Company, Eckert and Ziegler AG, Elekta AB, GE Healthcare Technologies Inc, Hitachi Ltd, iCAD Inc, Ion Beam Applications SA, IsoRay Inc, Koninklijke Philips N.V., Mitsubishi Heavy Industries Ltd,, Nasdaq Inc, Neusoft Corp, Shinva Medical Instrument Co.Ltd., Siemens Healthineers AG, Theragenics Corp, Toshiba Corp, ViewRay Inc, Vision RT Ltd.
A significant trend in radiotherapy devices is the continuous advancements in treatment delivery and imaging technology. Radiotherapy plays a crucial role in cancer treatment, delivering targeted radiation to destroy cancer cells while minimizing damage to surrounding healthy tissues. Recent developments in radiotherapy devices include the integration of advanced imaging modalities such as positron emission tomography (PET), magnetic resonance imaging (MRI), and cone-beam computed tomography (CBCT) into treatment systems, enabling real-time image guidance, tumor tracking, and adaptive treatment planning. Additionally, innovations in treatment delivery techniques such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic radiosurgery (SRS) allow for more precise and effective radiation delivery, improving treatment outcomes and reducing treatment-related side effects. This trend towards technological advancements reflects the ongoing demand for state-of-the-art radiotherapy devices that offer improved treatment accuracy, efficiency, and patient comfort.
The increasing incidence of cancer and the growing adoption of radiotherapy serve as significant market drivers for radiotherapy devices. Cancer is a leading cause of morbidity and mortality worldwide, with millions of new cases diagnosed each year. Radiotherapy is an essential component of cancer treatment, used either as a primary treatment modality or in combination with surgery, chemotherapy, or immunotherapy to achieve local tumor control and improve survival rates. As the global burden of cancer continues to rise, fueled by factors such as population growth, aging demographics, and lifestyle changes, there's a growing demand for radiotherapy devices that can deliver precise and effective radiation treatments to a larger number of cancer patients. This driver underscores the importance of investing in radiotherapy technology to meet the increasing demand for cancer care and improve access to radiotherapy services for patients around the world.
A promising opportunity in the radiotherapy devices market lies in the development of compact and affordable treatment systems that can expand access to radiotherapy services in resource-limited settings and emerging markets. Traditional radiotherapy devices such as linear accelerators (LINACs) and gamma knife radiosurgery systems are often large, expensive, and require specialized infrastructure and trained personnel for installation and operation, limiting their accessibility in low- and middle-income countries. By investing in the development of compact and cost-effective radiotherapy devices, such as portable LINACs, low-energy X-ray machines, and brachytherapy systems, companies can address the unmet need for affordable cancer treatment options and improve patient outcomes in underserved regions. Additionally, collaborating with local healthcare providers, governments, and non-governmental organizations to implement training programs, establish treatment centers, and promote awareness of radiotherapy services can further enhance the adoption and utilization of radiotherapy devices in resource-constrained settings. Investing in the development of compact and affordable treatment systems presents a strategic opportunity for companies to expand their market reach, address global health disparities, and make a meaningful impact on cancer care delivery worldwide.
Among radiotherapy devices, the external beam segment is experiencing the most rapid growth. External beam radiotherapy involves the delivery of high-energy radiation beams from a machine outside the patient's body to target and destroy cancerous cells. This technique is widely utilized in the treatment of various cancers, including breast, lung, prostate, and head and neck cancers. The increasing incidence of cancer worldwide, coupled with advancements in radiotherapy technology, has propelled the demand for external beam radiotherapy devices. Modern external beam systems offer enhanced precision, efficiency, and patient comfort, with advanced features such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT). These innovations allow for more targeted and effective treatment delivery while minimizing radiation exposure to surrounding healthy tissues. As healthcare facilities, including hospitals, ambulatory surgical centers, and oncological treatment centers, strive to meet the growing demand for cancer care, investments in external beam radiotherapy devices are expected to drive significant market growth.
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AngioDynamics Inc
Becton, Dickinson and Company
Eckert and Ziegler AG
Elekta AB
GE Healthcare Technologies Inc
Hitachi Ltd
iCAD Inc
Ion Beam Applications SA
IsoRay Inc
Koninklijke Philips N.V.
Mitsubishi Heavy Industries Ltd,
Nasdaq Inc
Neusoft Corp
Shinva Medical Instrument Co.Ltd.
Siemens Healthineers AG
Theragenics Corp
Toshiba Corp
ViewRay Inc
Vision RT Ltd
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Radiotherapy Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Radiotherapy Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Radiotherapy Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Radiotherapy Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Radiotherapy Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Radiotherapy Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Radiotherapy Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Radiotherapy Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Radiotherapy Devices Industry
4.2 Key Market Trends in Radiotherapy Devices Industry
4.3 Potential Opportunities in Radiotherapy Devices Industry
4.4 Key Challenges in Radiotherapy Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Radiotherapy Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Radiotherapy Devices Market Outlook by Segments
7.1 Radiotherapy Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
8 North America Radiotherapy Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Radiotherapy Devices Markets in 2024
8.2 North America Radiotherapy Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Radiotherapy Devices Market size Outlook by Segments, 2021-2030
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
9 Europe Radiotherapy Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Radiotherapy Devices Markets in 2024
9.2 Europe Radiotherapy Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Radiotherapy Devices Market Size Outlook by Segments, 2021-2030
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
10 Asia Pacific Radiotherapy Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Radiotherapy Devices Markets in 2024
10.2 Asia Pacific Radiotherapy Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Radiotherapy Devices Market size Outlook by Segments, 2021-2030
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
11 South America Radiotherapy Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Radiotherapy Devices Markets in 2024
11.2 South America Radiotherapy Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Radiotherapy Devices Market size Outlook by Segments, 2021-2030
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
12 Middle East and Africa Radiotherapy Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Radiotherapy Devices Markets in 2024
12.2 Middle East and Africa Radiotherapy Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Radiotherapy Devices Market size Outlook by Segments, 2021-2030
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AngioDynamics Inc
Becton, Dickinson and Company
Eckert and Ziegler AG
Elekta AB
GE Healthcare Technologies Inc
Hitachi Ltd
iCAD Inc
Ion Beam Applications SA
IsoRay Inc
Koninklijke Philips N.V.
Mitsubishi Heavy Industries Ltd,
Nasdaq Inc
Neusoft Corp
Shinva Medical Instrument Co.Ltd.
Siemens Healthineers AG
Theragenics Corp
Toshiba Corp
ViewRay Inc
Vision RT Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
External beam
Internal beam
By End-User
Hospitals
Ambulatory Surgical Centers
Oncological Treatment Centers
The global Radiotherapy Devices Market is one of the lucrative growth markets, poised to register a 5.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AngioDynamics Inc, Becton, Dickinson and Company, Eckert and Ziegler AG, Elekta AB, GE Healthcare Technologies Inc, Hitachi Ltd, iCAD Inc, Ion Beam Applications SA, IsoRay Inc, Koninklijke Philips N.V., Mitsubishi Heavy Industries Ltd,, Nasdaq Inc, Neusoft Corp, Shinva Medical Instrument Co.Ltd., Siemens Healthineers AG, Theragenics Corp, Toshiba Corp, ViewRay Inc, Vision RT Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume